Endocrinology

Top Story

Insulin glargine, detemir effective in treating inpatient hyperglycemia

Insulin glargine, detemir effective in treating inpatient hyperglycemia
August 24, 2016

NEW ORLEANS — Insulin detemir and insulin glargine were found to be equally effective in managing patients with diabetes, with no significant differences between the two treatment options in regard to hospital readmission rate, glycemic control or hyperglycemia, according to study results presented at the American Diabetes Association Scientific Sessions.

“Our study was addressing a very common question that clinicians face on a daily basis, not just endocrinologists, but also internal medicine doctors and any provider that is taking care of a patient with diabetes in the hospital,” Rodolfo J. Galindo, MD, director of the hospital diabetes service at Mount Sinai St. Luke’s, told Endocrine Today.

In the Journals Plus

Food sequence at meals can influence glucose control in type 2 diabetes

August 24, 2016
Adults with well-controlled type 2 diabetes who consumed non-glucidic foods prior to high-carbohydrate foods at mealtime saw reduced glucose variability over 2 months…
In the Journals

Metformin effective for weight gain associated with atypical antipsychotic use in children

August 24, 2016
Metformin significantly improved BMI and weight outcomes among children and adolescents who experienced weight gain associated with atypical antipsychotic use for autism…
In the Journals Plus

Depression may drive health care costs in obesity

August 24, 2016
The presence of comorbidities and depression in adults with obesity may be a primary driver of high health care costs in the United Kingdom, according to recent…
In the Journals Plus

Endogenous glucagon production less suppressed with OGTT vs. glucose infusion

August 23, 2016
Oral glucose tolerance testing results in less-suppressed endogenous glucagon production compared with isoglycemic intravenous glucose infusion in adults with and…
More News Headlines »
CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Video
Meeting News Coverage

VIDEO: Meeting MC recalls diabetes care over the decades

August 14, 2016
More »
Featured
ADA 2016

ADA 2016

CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Current Issues
View the Current Issues
morganatic-roan